Russia stocks lower at close of trade; MOEX Russia Index down 0.67%

Earnings season continues, with a diverse array of companies gearing up to unveil their financial results for the upcoming trading day. Leading the charge are industry giants Starbucks, Chubb, Boeing, General Motors (NYSE:GM), and Lockheed Martin (NYSE:LMT), each poised to offer valuable insights into their respective sectors.

Earnings Before the Open:

• United Tech (NYSE:RTX): EPS $1.38, Revenue $20.53B

• SAP AG ADS-Exch (NYSE:SAP): EPS $1.50, Revenue $9.74B

• Boeing Co (NYSE:BA): EPS -$1.74, Revenue $17.04B

• Lockheed Martin (LMT): EPS $6.58, Revenue $18.84B

• General Motors (GM): EPS $1.72, Revenue $42.73B

• Kimberly Clark (NYSE:KMB): EPS $1.51, Revenue $4.86B

• Royal Caribbean (NYSE:RCL): EPS $1.49, Revenue $3.76B

• Paccar Inc (NASDAQ:PCAR): EPS $1.70, Revenue $7.57B

• Sysco Corp (NYSE:SYY): EPS $0.9223, Revenue $20.11B

• Atlas (NYSE:ATCO) Copco (ATLCY): EPS $0.1435, Revenue $4.22B

• Atlas Copco AB (ATLKY): EPS $0.1435, Revenue $4.22B

• Synchrony Fin (NYSE:SYF): EPS $1.89, Revenue $3.84B

• Invesco Ltd (NYSE:IVZ): EPS $0.4827, Revenue $1.16B

• Popular Inc (NASDAQ:BPOP): EPS $2.06, Revenue $754.72M

• Polaris Industries (NYSE:PII): EPS $0.8956, Revenue $1.69B

• Jet Blue (NASDAQ:JBLU): EPS -$0.347, Revenue $2.25B

• Xerox Corp (NASDAQ:XRX): EPS $0.6667, Revenue $1.69B

• Commvault System (NASDAQ:CVLT): EPS $0.8743, Revenue $245.93M

• Nextera Energy Partners LP (NYSE:NEP): EPS $0.712, Revenue $288.59M

• Adient PLC (NYSE:ADNT): EPS $0.3145, Revenue $3.44B

• Camden National ({{167|CANASDAQ:CAC): EPS $0.8825, Revenue $45.36M

• World Acceptance (NASDAQ:WRLD): EPS $1.23, Revenue $136.67M

• Provident Financial Holdings (NASDAQ:PROV): EPS $0.28, Revenue $9.68M

Earnings After the Close:

• Starbucks Corp (NASDAQ:SBUX): EPS $0.6803, Revenue $9.35B

• Chubb Corp (NYSE:CB): EPS $5.34, Revenue $12.26B

• Stryker (NYSE:SYK): EPS $3.87, Revenue $6.36B

• Boston Ppty (NYSE:BXP): EPS $0.4823, Revenue $836.85M

• F5 Networks Inc (NASDAQ:FFIV): EPS $3.36, Revenue $715.45M

• Manhattan Associa (NASDAQ:MANH): EPS $1.06, Revenue $253.55M

• Qorvo Inc (NASDAQ:QRVO): EPS $1.21, Revenue $902.6M

• Packaging Corp (NYSE:PKG): EPS $2.51, Revenue $2.12B

• Logitech International S.A.-Exch (NASDAQ:LOGI): EPS $1.37, Revenue $1.25B

• RenaissanceRe Holdings Ltd (NYSE:RNR): EPS $6.49, Revenue $2.41B

• Littelfuse (NASDAQ:LFUS): EPS $2.36, Revenue $523.3M

• Nextracker (NXT): EPS $0.48, Revenue $617.99M

• Houlihan Lokey Inc (NYSE:HLI): EPS $1.49, Revenue $591.45M

• UMB Financial Corp (NASDAQ:UMBF): EPS $2.26, Revenue $411.97M

• Ashland Inc (NYSE:ASH): EPS $0.24, Revenue $431.72M

• K12 Inc (NYSE:LRN): EPS $1.92, Revenue $562.39M

• BofI Holding (NYSE:AX): EPS $1.75, Revenue $303.63M

• First Commonwealth Financial Corp (NYSE:FCF): EPS $0.3557, Revenue $119.68M

• Veritex Holdings Inc (NASDAQ:VBTX): EPS $0.5583, Revenue $112.52M

• Provident Financial Services Inc (NYSE:PFS): EPS $0.50, Revenue $210.6M

• Renasant Corp (RNST): EPS $0.5733, Revenue $167.42M

• Trustmark Corp (NASDAQ:TRMK): EPS $0.816, Revenue $194.94M

• LendingClub Corp (NYSE:LC): EPS $0.0906, Revenue $206.43M

• HAFC (NASDAQ:HAFC): EPS $0.5149, Revenue $61.44M

• Flushing Financial (NASDAQ:FFIC): EPS $0.2125, Revenue $51.02M

• Alerus Financial Corp (NASDAQ:ALRS): EPS $0.366, Revenue $60.52M

• GBank Financial Holdings (GBFH): EPS $0.33, Revenue N/A

• Metals Acquisition (MTAL): EPS $0.12, Revenue $79.26M

• Keegan Resources BATS (NYSE:GAU): EPS $0.058, Revenue $85.39M

• Southern National Bancorp (FRST): EPS $0.48, Revenue $33.11M

Stay informed about the latest earnings reports and real-time results by checking back daily at Investing.com's Earnings Calendar and Headlines. Do you want to trade the earnings of the biggest companies like a pro? Then get InvestingPro now and access over 1000 metrics that will give you a significant advantage in the shark tank that is Wall Street. Click here.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com – Russia stocks were higher after the close on Friday, as gains in the Mining, Telecoms and Power sectors led shares higher.

At the close in Moscow, the MOEX Russia Index gained 0.91%.

The best performers of the session on the MOEX Russia Index were PIK SHb PJSC (MCX:PIKK), which rose 4.53% or 31.50 points to trade at 727.00 at the close. Meanwhile, Polyus PJSC (MCX:PLZL) added 3.84% or 632.50 points to end at 17,098.00 and Moskovskaya Birzha PJSC (MCX:MOEX) was up 2.36% or 4.86 points to 211.20 in late trade.

The worst performers of the session were OK Rusal MKPAO (MCX:RUAL), which fell 1.62% or 0.61 points to trade at 36.76 at the close. AFK Sistema PJSC (MCX:AFKS) declined 1.57% or 0.24 points to end at 14.72 and ADS Ozon Holdings PLC ORD SHS (MCX:OZONDR) was down 1.46% or 52.00 points to 3,511.50.

Rising stocks outnumbered declining ones on the Moscow Stock Exchange by 146 to 98 and 10 ended unchanged.

Shares in Polyus PJSC (MCX:PLZL) rose to 3-years highs; gaining 3.84% or 632.50 to 17,098.00.

The Russian Volatility Index – RVI, which measures the implied volatility of MOEX Russia Index options, was down 2.87% to 35.23.

Gold Futures for February delivery was up 0.46% or 12.76 to $2,777.76 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in March fell 0.03% or 0.02 to hit $74.60 a barrel, while the March Brent oil contract rose 0.18% or 0.14 to trade at $78.43 a barrel.

USD/RUB was down 2.08% to 97.80, while EUR/RUB fell 1.32% to 102.64.

The US Dollar Index Futures was down 0.56% at 107.25.

Investing.com -- Ascentage Pharma's (NASDAQ: AAPG) IPO began trading Friday on the NASDAQ. Shares opened at $17.25 per ADS, in line with the initial public offering (IPO) price of $17.25. The pharmaceutical company, already listed on the Main Board of the Stock Exchange of Hong Kong Limited under the code 6855.HK since October 2019, issued 7,325,000 American depositary shares (ADS).

Each ADS corresponds to four ordinary shares of Ascentage Pharma. The gross income from the IPO, before subtracting underwriting discounts, commissions, and other related expenses, is projected to be around $126.4 million.

The company has also provided the underwriters with a 30-day option to acquire up to an additional 1,098,750 ADSs at the initial IPO price, excluding underwriting discounts and commissions. The ADSs were expected to begin trading on the Nasdaq Global Market on January 24, 2025, under the ticker "AAPGV" on a "when-issued" basis. Regular trading under the symbol "AAPG" is set to commence on January 27, 2025. The offering is slated to close on January 28, 2025, pending standard closing conditions.

J.P. Morgan and Citigroup (NYSE:C) are serving as joint book-running managers for the offering. Ascentage Pharma, a global, integrated biopharmaceutical company, focuses on discovering, developing, and commercializing therapies to address global unmet medical needs, primarily in hematological malignancies.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com-- Ascentage Pharma Group International (HK:6855) shares plunged on Friday in Hong Kong trading, as investors turned cautious ahead of the biotech firm’s American Depositary Shares (ADS) debut on the Nasdaq later in the day.

The sell-off underscores investor caution as the company prepares for its U.S. listing, which will allow global investors to trade its shares more easily.

China-based Ascentage Pharma, which specializes in cancer therapies, had on Tuesday announced the pricing of its ADS offering at $20.34 per share, aiming to raise around $149 million, but lowered the pricing to $17.25 each on Friday to raise $126 million.

Hong Kong-listed shares of the company fell 12.5% to HK$36.55 as of 05:43 GMT.

Ascentage is backed by Japan's biggest drugmaker Takeda Pharmaceutical Co., Ltd. (TYO:4502)

The firm plans to use the proceeds from the ADS sale to advance clinical trials, research, and development of its targeted therapies and apoptosis-based drug candidates. However, concerns about market volatility and the potential dilution of shares have weighed on investor sentiment, contributing to the sharp decline.

This offering marks the latest move in a trend of dual listings by Chinese biotech firms seeking to broaden their investor base and raise capital from U.S. markets.

Investing.com – Russia stocks were lower after the close on Thursday, as losses in the Telecoms, Mining and Oil & Gas sectors led shares lower.

At the close in Moscow, the MOEX Russia Index declined 1.65%.

The best performers of the session on the MOEX Russia Index were PIK SHb PJSC (MCX:PIKK), which rose 6.82% or 44.50 points to trade at 697.40 at the close. Meanwhile, ADS Ozon Holdings PLC ORD SHS (MCX:OZONDR) added 4.12% or 141.00 points to end at 3,563.00 and AFK Sistema PJSC (MCX:AFKS) was up 2.91% or 0.42 points to 14.97 in late trade.

The worst performers of the session were AK ALROSA PJSC (MCX:ALRS), which fell 1.65% or 0.92 points to trade at 55.00 at the close. Magnitogorskiy Metallurgicheskiy Kombinat PAO (MCX:MAGN) declined 0.97% or 0.36 points to end at 36.15 and Rostelekom PJSC (MCX:RTKM) was down 0.91% or 0.61 points to 66.48.

Falling stocks outnumbered advancing ones on the Moscow Stock Exchange by 141 to 107 and 4 ended unchanged.

The Russian Volatility Index – RVI, which measures the implied volatility of MOEX Russia Index options, was up 2.83% to 36.73.

Gold Futures for February delivery was down 0.34% or 9.39 to $2,761.51 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in March fell 1.62% or 1.22 to hit $74.22 a barrel, while the March Brent oil contract fell 1.48% or 1.17 to trade at $77.83 a barrel.

USD/RUB was up 0.62% to 99.87, while EUR/RUB rose 0.75% to 104.06.

The US Dollar Index Futures was down 0.02% at 107.94.